The Emerging Role of CJC-1295 no DAC in Laboratory Studies
In controlled research settings, CJC-1295 without DAC (Drug Affinity Complex) represents a synthetic analog of growth hormone-releasing hormone (GHRH), designed to stimulate endogenous growth hormone secretion. Unlike its DAC-containing counterpart, this variant exhibits a shorter biological half-life, allowing researchers to study pulsatile growth hormone release patterns more accurately. Preclinical investigations often focus on its receptor-binding…